267 related articles for article (PubMed ID: 9519889)
1. Inhibition of human immunodeficiency virus type 1 replication by a bioavailable serine/threonine kinase inhibitor, fasudil hydrochloride.
Sato T; Asamitsu K; Yang JP; Takahashi N; Tetsuka T; Yoneyama A; Kanagawa A; Okamoto T
AIDS Res Hum Retroviruses; 1998 Mar; 14(4):293-8. PubMed ID: 9519889
[TBL] [Abstract][Full Text] [Related]
2. Anti-rheumatic compound aurothioglucose inhibits tumor necrosis factor-alpha-induced HIV-1 replication in latently infected OM10.1 and Ach2 cells.
Traber KE; Okamoto H; Kurono C; Baba M; Saliou C; Soji T; Packer L; Okamoto T
Int Immunol; 1999 Feb; 11(2):143-50. PubMed ID: 10069412
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of human immunodeficiency virus type 1 replication by blocking IkappaB kinase with noraristeromycin.
Asamitsu K; Yamaguchi T; Nakata K; Hibi Y; Victoriano AF; Imai K; Onozaki K; Kitade Y; Okamoto T
J Biochem; 2008 Nov; 144(5):581-9. PubMed ID: 18713798
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of human immunodeficiency virus type 1 replication in latently infected cells by a novel IkappaB kinase inhibitor.
Victoriano AF; Asamitsu K; Hibi Y; Imai K; Barzaga NG; Okamoto T
Antimicrob Agents Chemother; 2006 Feb; 50(2):547-55. PubMed ID: 16436709
[TBL] [Abstract][Full Text] [Related]
5. Potent inhibition of HIV type 1 replication by an antiinflammatory alkaloid, cepharanthine, in chronically infected monocytic cells.
Okamoto M; Ono M; Baba M
AIDS Res Hum Retroviruses; 1998 Sep; 14(14):1239-45. PubMed ID: 9764907
[TBL] [Abstract][Full Text] [Related]
6. ERK MAP kinase links cytokine signals to activation of latent HIV-1 infection by stimulating a cooperative interaction of AP-1 and NF-kappaB.
Yang X; Chen Y; Gabuzda D
J Biol Chem; 1999 Sep; 274(39):27981-8. PubMed ID: 10488148
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of HIV-1 Nef-induced apoptosis of uninfected human blood cells by serine/threonine protein kinase inhibitors, fasudil hydrochloride and M3.
Okada H; Takei R; Tashiro M
FEBS Lett; 1998 Feb; 422(3):363-7. PubMed ID: 9498817
[TBL] [Abstract][Full Text] [Related]
8. Suppression of HIV-1 replication in peripheral blood mononuclear cells by fasudil.
Akari H; Yamamoto Y; Hiwada H; Saito Y; Takayanagi N; Koyama AH; Adachi A
J Med Invest; 1998 Feb; 44(3-4):211-4. PubMed ID: 9597811
[TBL] [Abstract][Full Text] [Related]
9. Interleukin 1 induces HIV-1 expression in chronically infected U1 cells: blockade by interleukin 1 receptor antagonist and tumor necrosis factor binding protein type 1.
Granowitz EV; Saget BM; Wang MZ; Dinarello CA; Skolnik PR
Mol Med; 1995 Sep; 1(6):667-77. PubMed ID: 8529133
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of herpesvirus-induced HIV-1 replication by cyclopentenone prostaglandins: role of IkappaB kinase (IKK).
Amici C; Belardo G; Rozera C; Bernasconi D; Santoro MG
AIDS; 2004 Jun; 18(9):1271-80. PubMed ID: 15362659
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of replication of reactivated human immunodeficiency virus type 1 (HIV-1) in latently infected U1 cells transduced with an HIV-1 long terminal repeat-driven PKR cDNA construct.
Muto NF; Martinand-Mari C; Adelson ME; Suhadolnik RJ
J Virol; 1999 Nov; 73(11):9021-8. PubMed ID: 10516008
[TBL] [Abstract][Full Text] [Related]
12. Alpha-1-antitrypsin inhibits human immunodeficiency virus type 1.
Shapiro L; Pott GB; Ralston AH
FASEB J; 2001 Jan; 15(1):115-122. PubMed ID: 11149899
[TBL] [Abstract][Full Text] [Related]
13. Dioxin activates human immunodeficiency virus-1 expression in chronically infected promonocytic U1 cells by enhancing NF-kappa B activity and production of tumor necrosis factor-alpha.
Gollapudi S; Kim CH; Patel A; Sindhu R; Gupta S
Biochem Biophys Res Commun; 1996 Sep; 226(3):889-94. PubMed ID: 8831706
[TBL] [Abstract][Full Text] [Related]
14. Synergistic activation of human immunodeficiency virus type 1 promoter activity by NF-kappaB and inhibitors of deacetylases: potential perspectives for the development of therapeutic strategies.
Quivy V; Adam E; Collette Y; Demonte D; Chariot A; Vanhulle C; Berkhout B; Castellano R; de Launoit Y; Burny A; Piette J; Bours V; Van Lint C
J Virol; 2002 Nov; 76(21):11091-103. PubMed ID: 12368351
[TBL] [Abstract][Full Text] [Related]
15. Soluble tumor necrosis factor receptors inhibit phorbol myristate acetate and cytokine-induced HIV-1 expression chronically infected U1 cells.
Granowitz EV; Saget BM; Angel JB; Wang MZ; Wang A; Dinarello CA; Skolnik PR
J Acquir Immune Defic Syndr Hum Retrovirol; 1996 Apr; 11(5):430-7. PubMed ID: 8605587
[TBL] [Abstract][Full Text] [Related]
16. Isoquinolinesulphonamide derivatives inhibit transcriptional elongation of human immunodeficiency virus type 1 RNA in a promyelocytic model of latency.
Critchfield JW; Ho O; Roberts BD; Van Lint C; Verdin E; Butera ST
Antivir Chem Chemother; 1999 Sep; 10(5):275-84. PubMed ID: 10574182
[TBL] [Abstract][Full Text] [Related]
17. Iron chelation decreases NF-kappa B and HIV type 1 activation due to oxidative stress.
Sappey C; Boelaert JR; Legrand-Poels S; Forceille C; Favier A; Piette J
AIDS Res Hum Retroviruses; 1995 Sep; 11(9):1049-61. PubMed ID: 8554902
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of active HIV-1 replication by NF-kappaB inhibitor DHMEQ.
Miyake A; Ishida T; Yamagishi M; Hara T; Umezawa K; Watanabe T; Horie R
Microbes Infect; 2010 May; 12(5):400-8. PubMed ID: 20172044
[TBL] [Abstract][Full Text] [Related]
19.
de Jesus MSM; Macabeo APG; Ramos JDA; de Leon VNO; Asamitsu K; Okamoto T
Molecules; 2022 Feb; 27(3):. PubMed ID: 35164343
[TBL] [Abstract][Full Text] [Related]
20. IL-10 cooperates with TNF-alpha to activate HIV-1 from latently and acutely infected cells of monocyte/macrophage lineage.
Finnegan A; Roebuck KA; Nakai BE; Gu DS; Rabbi MF; Song S; Landay AL
J Immunol; 1996 Jan; 156(2):841-51. PubMed ID: 8543841
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
